Cargando…
Follicle‐Stimulating Hormone, Its Association with Cardiometabolic Risk Factors, and 10‐Year Risk of Cardiovascular Disease in Postmenopausal Women
BACKGROUND: Cardiovascular disease is the leading cause of mortality in postmenopausal women. Follicle‐stimulating hormone (FSH) shows negative associations with obesity and diabetes mellitus in postmenopausal women. We aimed to study the associations between FSH and 10‐year risk of atherosclerotic...
Autores principales: | Wang, Ningjian, Shao, Hongfang, Chen, Yi, Xia, Fangzhen, Chi, Chen, Li, Qin, Han, Bing, Teng, Yincheng, Lu, Yingli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634260/ https://www.ncbi.nlm.nih.gov/pubmed/28855169 http://dx.doi.org/10.1161/JAHA.117.005918 |
Ejemplares similares
-
Follicle-stimulating hormone associates with prediabetes and diabetes in postmenopausal women
por: Wang, Ningjian, et al.
Publicado: (2015) -
Association of follicle-stimulating hormone with lipid profiles in older women: a cross-sectional SPECT-China study
por: Zhang, Wen, et al.
Publicado: (2023) -
Are Thyroid Autoimmune Diseases Associated with Cardiometabolic Risks in a Population with Normal Thyroid-Stimulating Hormone?
por: Chen, Yi, et al.
Publicado: (2018) -
Follicle‐stimulating hormone promotes renal tubulointerstitial fibrosis in aging women via the AKT/GSK‐3β/β‐catenin pathway
por: Zhang, Kun, et al.
Publicado: (2019) -
Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation
por: Wang, Jie, et al.
Publicado: (2015)